Feed SGIPF
SG

Sugi Holdings Co.,Ltd. SGIPF OTC · Healthcare · Japan

$8.09 +0.00% +$0.00

Summary

66 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 491% a year over the last 3 years.
  • It holds more cash than debt: ¥118.6B against ¥91.9B.
  • The share price is below the Bulios Fair Price.

What to watch

  • It missed profit estimates 5 times in the last 6 quarters.
  • Out of every 100 JPY of revenue, only 2.8 JPY is left as net profit.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $8.09

By our assumptions the business is worth more than its shares cost today.

P/E today 16.3 97% lower
5-year average P/E 589.5
P/E today 16.3
Medical - Pharmaceuticals industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 16.3 JPY for 1 JPY of yearly profit. Over the last five years it was 589.5 JPY on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (JPY)

Diluted EPS (JPY)

  • Analyst estimate

Revenue grew by 182% a year over 5 years. Over the last 3 years it grew by 491% a year. For the next fiscal year analysts expect revenue to grow by 9.8%.

Growth in detail

Does it make money?

Poorly

Where 100 JPY of revenue goes

Net profit, industry median (Medical - Pharmaceuticals) 6.1 JPY

Out of every 100 JPY of revenue, 2.8 JPY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, at risk
Yield
2.17%
Paid out of profit
35%
Raised in a row
2 years

You receive $0.18 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy